NAPS2 recruitment and support program for REM sleep behavior disorder
NAPS2 Recruitment, Education, and Outreach Core
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11321185
This program connects people with REM sleep behavior disorder and their caregivers to multisite research, offers education, and helps centers recruit and keep a diverse group of participants.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11321185 on ClinicalTrials.gov |
What this research studies
As someone with REM sleep behavior disorder (RBD), this program helps me find and join research being done at multiple centers across North America. It works with clinics to recruit people, supports retention so participants stay involved over time, and runs education sessions for patients, families, and clinicians. The team reaches out to community groups and industry partners to build long-term relationships and improve awareness of RBD. The effort focuses on enrolling a diverse group of participants and providing ongoing outreach and information.
Who could benefit from this research
Good fit: Adults diagnosed with or suspected to have REM sleep behavior disorder and their caregivers who can be contacted by or travel to participating NAPS2 centers are ideal candidates.
Not a fit: People without RBD, those unwilling to share health information, or those who cannot access participating centers are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this core could make it easier for people with RBD to join research, get up-to-date education, and speed discoveries that lead to better care.
How similar studies have performed: This builds on the earlier NAPS1 effort that enrolled over 200 participants across 10 sites, so it expands an existing, proven multisite recruitment and outreach model.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VIDENOVIC, ALEKSANDAR — WASHINGTON UNIVERSITY
- Study coordinator: VIDENOVIC, ALEKSANDAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.